Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-08-18

FDA Approved: FLUOROURACIL — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for fluorouracil submitted by Mylan Pharmaceuticals, resulting in an updated regulatory status for the drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLUOROURACIL (Fluorouracil)

Snippet

SUPPL AP for FLUOROURACIL (FLUOROURACIL)